ArticleBritish journal of haematology2026
Matching-adjusted indirect comparisons of efficacy and safety for zanubrutinib versus the combination of fixed-duration venetoclax and ibrutinib in patients with treatment-naïve chronic lymphocytic leukaemia.
Talha Munir et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.